German Company in $3.9 Billion Deal to Buy US Biotech Firm SpringWorks
- by: Chase Smith
- 2025-04-28
- Source:
The Epoch Times
- 04/28/2025
Merck will acquire SpringWorks Therapeutics for $3.9 billion, aiming to strengthen its U.S. health care presence and expand rare tumor therapies worldwide.
Get latest news delivered daily!
We will send you breaking news right to your inbox
[ADD FORM IN PSYCODE "follow-us-card"]Have a tip? Let us know!
Recent Articles
